Norges Bank Beam Therapeutics Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$21.22 - $32.66 $8.72 Million - $13.4 Million	410,799 New	410,799 $9.63 Million
Q4 2023 Feb 09, 2024	BUY	$17.69 - $30.76 $227,971 - $396,404	12,887 New	12,887 $350,000
Q3 2023 Nov 13, 2024	BUY	$23.01 - $32.46 $6.94 Million - $9.79 Million	301,724 New	301,724 $7.26 Million
Q3 2023 Nov 13, 2023	SELL	$23.01 - $32.46 $10.8 Million - $15.2 Million	-469,008 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$29.32 - $35.99 $3 Million - $3.68 Million	-102,165 Reduced 24.87%	308,634 $9.85 Million
Q2 2023 Aug 14, 2023	SELL	$29.32 - $35.99 $13.2 Million - $16.2 Million	-449,889 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$30.15 - $48.79 $11.9 Million - $19.2 Million	394,263 New	394,263 $12.1 Million
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $18.3 Million - $25.7 Million	498,011 New	498,011 $19.5 Million
Q3 2022 Nov 13, 2023	BUY	$39.79 - $70.31 $18.7 Million - $33 Million	469,008 New	469,008 $22.3 Million
Q2 2022 Aug 14, 2023	BUY	$29.86 - $62.36 $13.4 Million - $28.1 Million	449,889 New	449,889 $17.4 Million
Q1 2022 May 12, 2023	SELL	$53.73 - $82.16 $11.3 Million - $17.3 Million	-210,775 Reduced 42.32%	287,236 $16.5 Million
Q1 2022 May 09, 2022	SELL	$53.73 - $82.16 $15.2 Million - $23.2 Million	-282,666 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$68.02 - $99.06 $19.2 Million - $28 Million	282,666 New	282,666 $22.5 Million
Q3 2021 Nov 14, 2022	BUY	$84.37 - $133.6 $26.5 Million - $41.9 Million	313,553 New	313,553 $27.3 Million
Q3 2021 Nov 05, 2021	SELL	$84.37 - $133.6 $24 Million - $38 Million	-284,061 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$64.12 - $128.71 $18.2 Million - $36.6 Million	284,061 New	284,061 $36.6 Million
Q2 2021 Aug 10, 2021	SELL	$64.12 - $128.71 $19.8 Million - $39.8 Million	-309,382 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$71.28 - $120.75 $22.1 Million - $37.4 Million	309,382 New	309,382 $24.8 Million
Q3 2020 Nov 10, 2020	SELL	$19.0 - $30.57 $158,156 - $254,464	-8,324 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$15.26 - $28.66 $127,024 - $238,565	8,324 New	8,324 $233,000
Q2 2020 Aug 07, 2020	SELL	$15.26 - $28.66 $305,200 - $573,200	-20,000 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$13.31 - $29.2 $266,200 - $584,000	20,000 New	20,000 $360,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

Farallon Capital Management LLC San Francisco, CA

8.21M
Shares

$238 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.84M
Shares

$228 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.63M
Shares

$221 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

6.53M
Shares

$189 Million
1.52% of portfolio
Arch Venture Management, LLC Chicago, IL

4.83M
Shares

$140 Million
71.21% of portfolio

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.04B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account